基于18F-FDG PET/CT代谢参数的列线图在肝移植前预测肝细胞癌微血管侵犯的潜力
本研究回顾性纳入83例肝移植前接受18F-FDG PET/CT的肝细胞癌患者,41%经组织学诊断微血管侵犯。多因素logistic回归显示Child-Pugh分期、甲胎蛋白、肿瘤数目、CT Dmax和肿瘤与正常肝摄取比(TLR)为显著预测因子,构建的列线图校准良好,AUC为0.965(95%CI 0.925-1.000)。
要点
- 肿瘤与正常肝摄取比(TLR)是微血管侵犯的显著预测因子。
- 基于PET/CT代谢参数联合临床指标的列线图预测微血管侵犯AUC达0.965。
- 列线图预测概率与实际微血管侵犯概率校准良好。
核心结论
- 基于18F-FDG PET/CT代谢特征的列线图是肝移植前预测肝细胞癌微血管侵犯的可靠术前影像生物标志物,具有良好效能和高临床适用性。
研究设计与样本
- 回顾性研究纳入83例肝移植前接受18F-FDG PET/CT的肝细胞癌患者,采用logistic和Cox回归模型筛选微血管侵犯相关参数并构建列线图,以校准曲线和ROC曲线评估模型区分能力。
关键影像表现/征象
- 多因素logistic回归显示Child-Pugh分期、甲胎蛋白、肿瘤数目、CT Dmax和肿瘤与正常肝摄取比(TLR)为微血管侵犯的显著预测因子。
诊断标准与关键数值
- 列线图预测微血管侵犯的AUC为0.965(95%CI 0.925-1.000)。
临床应用与阅片要点
- 作者认为基于18F-FDG PET/CT代谢特征的列线图可用于肝移植前预测肝细胞癌微血管侵犯,具有高临床适用性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Microvascular invasion (MVI) is a critical factor in predicting the recurrence and prognosis of hepatocellular carcinoma (HCC) after liver transplantation (LT). However, there is a lack of reliable preoperative predictors for MVI. The purpose of this study is to evaluate the potential of an 18F-FDG PET/CT-based nomogram in predicting MVI before LT for HCC.
METHODS: 83 HCC patients who obtained 18F-FDG PET/CT before LT were included in this retrospective research. To determine the parameters connected to MVI and to create a nomogram for MVI prediction, respectively, Logistic and Cox regression models were applied. Analyses of the calibration curve and receiver operating characteristic (ROC) curves were used to assess the model's capability to differentiate between clinical factors and metabolic data from PET/CT images.
RESULTS: Among the 83 patients analyzed, 41% were diagnosed with histologic MVI. Multivariate logistic regression analysis revealed that Child-Pugh stage, alpha-fetoprotein, number of tumors, CT Dmax, and Tumor-to-normal liver uptake ratio (TLR) were significant predictors of MVI. A nomogram was constructed using these predictors, which demonstrated strong calibration with a close agreement between predicted and actual MVI probabilities. The nomogram also showed excellent differentiation with an AUC of 0.965 (95% CI 0.925-1.000).
CONCLUSION: The nomogram based on 18F-FDG PET/CT metabolic characteristics is a reliable preoperative imaging biomarker for predicting MVI in HCC patients before undergoing LT. It has demonstrated excellent efficacy and high clinical applicability.
引用
- Jiang S, Gao X, Tian Y, et al. The potential of 18F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantation. Abdom Radiol (NY). 2024. PMID: 38265452. doi:10.1007/s00261-023-04166-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。